S L. Gray, et.al., Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism., Molecular endocrinology (Baltimore, Md.), 2001, 15

http://rdf.ncbi.nlm.nih.gov/pubmed/11579206

S L. Gray, et.al., Targeted disruption of the pituitary adenylate cyclase-activating polypeptide gene results in early postnatal death associated with dysfunction of lipid and carbohydrate metabolism., Molecular endocrinology (Baltimore, Md.), 2001, 15

pubmed

allele

http://purl.org/net/cito/citesAsAuthority

• Adcyap1<tm1Nms>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2386973

表現型アノテーション

http://purl.org/net/cito/citesAsAuthority

• increased circulating insulin level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0002079EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• increased circulating free fatty acid level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0001554EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• postnatal lethality, complete penetrance_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0011085EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• increased circulating cholesterol level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0005178EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• abnormal skeletal muscle morphology_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0000759EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• hepatic steatosis_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0002628EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• increased circulating ketone body level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0002575EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• weight loss_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0001263EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• increased circulating triglyceride level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0001552EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• decreased glycogen level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0005439EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• hypoglycemia_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0000189EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• decreased white adipose tissue amount_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0001783EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms
• increased circulating corticosterone level_Adcyap1<tm1Nms>/Adcyap1<tm1Nms>
  http://metadb.riken.jp/0001745EI129S1Sv129X1SvJC57BL6orIC57BL6Adcyap1tm1NmsAdcyap1tm1NmsAdcyap1tm1Nms

class

http://purl.org/net/cito/citesAsAuthority

• Adcyap1<tm1Nms>
  http://metadb.riken.jp/db/mgi_rdf/MGI:2386973